Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts
- 31 December 2010
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 177 (6), 2804-2815
- https://doi.org/10.2353/ajpath.2010.100378
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Inflammatory Bowel DiseaseThe New England Journal of Medicine, 2009
- RIG-I-like receptors: Sensing and responding to RNA virus infectionSeminars in Immunology, 2009
- Interleukin-33 Is Biologically Active Independently of Caspase-1 CleavageOnline Journal of Public Health Informatics, 2009
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences of the United States of America, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocketEMBO Reports, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences of the United States of America, 2007